PSI Structural Biology Knowledgebase

PSI | Structural Biology Knowledgebase
Header Icons

Related Articles
Protein Folding and Misfolding: It's the Journey, Not the Destination
March 2015
CCR5 and HIV Infection
January 2015
HIV/AIDS: Pre-fusion Env Exposed
January 2015
HIV/AIDS: Slide to Enter
January 2015
Updating ModBase
January 2015
Power in Numbers
August 2014
Quorum Sensing: A Groovy New Component
August 2014
Bacterial CDI Toxins
June 2014
Immunity: One Antibody to Rule Them All
June 2014
Virology: A Bat Influenza Hemagglutinin
March 2014
Virology: Making Sensitive Magic
March 2014
Virology: Visualizing Cyanophage Assembly
March 2014
Virology: Zeroing in on HBV Egress
March 2014
March 2014
Cas4 Nuclease and Bacterial Immunity
February 2014
Microbial Pathogenesis: A GNAT from Pseudomonas
February 2014
Microbial Pathogenesis: Targeting Drug Resistance in Mycobacterium tuberculosis
February 2014
Microbiome: The Dynamics of Infection
September 2013
Membrane Proteome: A Funnel-like Viroporin
August 2013
Infectious Diseases: A Pathogen Ubiquitin Ligase
May 2013
Infectious Diseases: A Shared Syringe
May 2013
Infectious Diseases: Determining the Essential Structome
May 2013
Infectious Diseases: Targeting Meningitis
May 2013
NDM-1 and Antibiotics
May 2013
Bacterial Hemophores
January 2013
Microbial Pathogenesis: Computational Epitope Prediction
January 2013
Microbial Pathogenesis: Influenza Inhibitor Screen
January 2013
Microbial Pathogenesis: Measles Virus Attachment
January 2013
Microbial Pathogenesis: NEAT Iron
January 2013
Membrane Proteome: Sphingolipid Synthesis Selectivity
December 2012
A signal sensing switch
September 2012
Gauging needle structure
July 2012
Anthrax Stealth Siderophores
June 2012
A Pseudomonas L-serine dehydrogenase
May 2012
Pilus Assembly Protein TadZ
April 2012
Making Lipopolysaccharide
January 2012
Superbugs and Antibiotic Resistance
December 2011
A change to resistance
November 2011
An effective and cooperative dimer
November 2011
The Perils of Protein Secretion
November 2011
Bacterial Armor
October 2011
Breaking down the defenses
September 2011
Moving some metal
August 2011
Capsid assembly in motion
April 2011
Know thy enemy … structurally
October 2010
Treating sleeping sickness
May 2010
Bacterial spore kinase
April 2010
Hemolysin BL
January 2010
Unusual cell division
October 2009
Anthrax evasion tactics
September 2009
Toxin-antitoxin VapBC-5
September 2009
Antibiotic target
August 2009
July 2009
Tackling influenza
June 2009
You look familiar: the Type VI secretion system
June 2009
Unique SARS
April 2009
Anthrax stealth molecule
March 2009
A new class of bacterial E3 ubiquitination enzymes
January 2009
Antiviral evasion
October 2008
SARS connections
September 2008
SARS Coronavirus Nonstructural Protein 1
June 2008

Research Themes Infectious diseases

Breaking down the defenses

SBKB [doi:10.1038/sbkb.2011.37]
Featured Article - September 2011
Short description: The structure of ISG15 bound to NS1B gives insight into the mechanism by which influenza B virus specifically targets humans.

An NS1B-NTR homodimer bound to two ISG15 molecules (PDB 3SDL). Reprinted with permission from Proc. Natl. Acad. Sci. USA 1 .

One of the primary methods of host defense in the battle against viruses is the interferon-induced ISG15 pathway, which inhibits the replication of several viruses, including influenza A and B viruses. ISG15 is an ubiquitin-like protein comprising two ubiquitin-like domains (UblDs) that are connected by a short linker. The ISG15 pathway closely parallels that of ubiquitin and other ubiquitin-like molecules, including activation by the E1 Ube1L, conjugation by the E2 UbcH8, and ligation by an E3 ligase, principally Herc5. This enzyme system conjugates ISG15 onto host and viral proteins.

To counter this antiviral mechanism, the influenza B virus has evolved the ability to inhibit ISG15 conjugation via its NS1 protein, NS1B. The N-terminal region of NS1B binds the N-terminal UblD of ISG15, although how this interaction leads to inhibition of the host antiviral response is not fully understood. Interestingly, the ability of NS1B to overcome the ISG15 barrier extends only to human and non-human primate ISG15; NS1B cannot bind mouse ISG15 and therefore primarily targets humans. It is known that the ISG15 linker region is important to this specificity, but whether NS1B binds the linker, or whether the linker instead regulates the conformation of ISG15 was not yet known.

To understand how NS1B enables the influenza B virus to overcome the interferon-mediated ISG15 response, Montelione, Guan, Krug, and colleagues (PSI NESG) solved the X-ray crystal structure of human ISG15 in complex with the N-terminal region of NS1B (NS1B-NTR). The complex is a heterotetramer, with the NS1B-NTR homodimer binding one ISG15 monomer on each side. Each ISG15 binding site on the NS1B-NTR dimer surface consists of residues from both monomers. The two ISG15 molecules have similar interactions with NS1B, with a few minor differences, although the biological importance of the asymmetry is not yet clear. The ISG15 linker binds the NS1B-NTR using species-specific residues in the linker, answering the question as to the role of the linker in binding NS1B. Additionally, ISG15 residues 38–51, which have several differences compared to mouse ISG15, make further contacts with NS1B-NTR, providing another level of sequence-specific recognition in this interaction.

Interestingly, the C-terminal UblD of ISG15, which is involved in conjugation, does not interact with the NS1B-NTR, and previous work has shown that NS1B-bound ISG15 can still interact with E1 and E2 conjugating enzymes. Therefore the mechanism by which NS1B inhibits ISG15 conjugation is still a mystery, although the interactions seen in the structure are crucial as mutating two key residues prevents NS1B from inhibiting ISG15 conjugation in cells. The authors propose that NS1B may function by sequestering ISG15 away from cellular interactions, an intriguing hypothesis that will undoubtedly be tested further. In the meantime, the structure presented here provides valuable insights into the mechanism of influenza B virus infection and potential sites for antiviral drug discovery efforts.

Steve Mason


  1. R. Guan et al. Structural basis for the sequence-specific recognition of human ISG15 by the NS1 protein of influenza B virus.
    Proc. Natl. Acad. Sci. USA (1 Aug 2011). doi:10.1073/pnas.1107032108

Structural Biology Knowledgebase ISSN: 1758-1338
Funded by a grant from the National Institute of General Medical Sciences of the National Institutes of Health